Background:Private general practitioners in Malaysia largely operates as solo practices
– prescribing and supplying medications to patients directly from
their clinics, thus posing risk of medication-related problems to consumers.
A pharmacy practice reform that integrates pharmacists into primary
healthcare clinics can be a potential initiative to promote quality use of
medication. This model of care is a novel approach in Malaysia and research
in the local context is required, especially from the perspectives of
pharmacists.Objective:To explore pharmacists’ views in integrating pharmacists into private
GP clinics in Malaysia.Methods:A combination of purposive and snowballing sampling was used to recruit
community and hospital pharmacists from urban areas in Malaysia to
participate either in focus groups or semi-structured interviews. A total of
2 focus groups and 4 semi-structured interviews were conducted. Sessions
were audio recorded, transcribed verbatim and thematically analysed using
NVivo 10.Results:Four major themes were identified: (1) Limited potential to expand
pharmacists’ roles, (2) Concerns about non-pharmacists dispensing
medicines in private GP clinics, (3) Lack of trust from consumers and
private GPs, (4) Cost implications. Participants felt that there was a
limited role for pharmacists in private GP clinics. This was because the
medication supply role is currently undertaken in private GP clinics without
the need of pharmacists. The perceived lack of trust from consumers and
private GPs towards pharmacists arises from the belief that healthcare is
the GPs’ responsibility. This suggests that there is a need for
increased public and GP awareness towards the capabilities of
pharmacists’ in medication management. Participants were concerned
about an increase in cost to private GP visits if pharmacists were to be
integrated. Nevertheless, some participants perceived the integration as a
means to reduce medical costs through improved quality use of medicines.Conclusion:Findings from the study provided a better understanding to help ascertain
pharmacists’ views on their readiness and acceptance in a potential
new model of practice.